ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-4.37%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$331M
AUM Growth
+$331M
(-10%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-5.34%
Top 10 Holdings %
Top 10 Hldgs %
52.13%
Holding
90
New
22
Increased
20
Reduced
16
Closed
27
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$14.2M |
| 2 |
Orthofix Medical
OFIX
|
$13.6M |
| 3 |
Centene
CNC
|
$12.4M |
| 4 |
McKesson
MCK
|
$8.93M |
| 5 |
Avantor
AVTR
|
$6.05M |
Top Sells
| 1 |
Sanofi
SNY
|
$21.3M |
| 2 |
Cencora
COR
|
$15.3M |
| 3 |
Dentsply Sirona
XRAY
|
$9.62M |
| 4 |
Becton Dickinson
BDX
|
$8.66M |
| 5 |
SI-BONE Inc
SIBN
|
$7.99M |
Sector Composition
| 1 | Healthcare | 80.72% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Centene
CNC
$14.3B
| $18.4M | 4.84% | 218,235 +147,426 | +208% | +$12.4M |
|
2
Labcorp
LH
$23.1B
| $16.2M | 4.26% | 61,279 -4,093 | -6% | -$1.08M |
|
3
AstraZeneca
AZN
$248B
| $15.9M | 4.2% | 240,271 -84,457 | -26% | -$5.6M |
|
|
4
Bristol-Myers Squibb
BMY
$96B
| $14.2M | 3.75% | +194,684 | New | +$14.2M |
|
|
5
Orthofix Medical
OFIX
$592M
| $14.2M | 3.75% | 434,803 +415,986 | +2,211% | +$13.6M |
|
6
Humana
HUM
$36.5B
| $12.7M | 3.34% | 29,120 -4,861 | -14% | -$2.12M |
|
7
Tenet Healthcare
THC
$16.3B
| $11.3M | 2.97% | 131,376 -15,553 | -11% | -$1.34M |
|
|
SYNH
8
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $9.98M | 2.63% | 123,232 +47,957 | +64% | +$3.88M |
|
|
9
Avantor
AVTR
$9.18B
| $9.67M | 2.55% | 285,901 +178,905 | +167% | +$6.05M |
|
10
Bio-Rad Laboratories Class A
BIO
$8.06B
| $9.66M | 2.54% | 17,151 +2,612 | +18% | +$1.47M |
|
11
Hologic
HOLX
$14.9B
| $9.5M | 2.5% | 123,624 -57,444 | -32% | -$4.41M |
|
|
12
SI-BONE Inc
SIBN
$719M
| $9.34M | 2.46% | 413,370 -353,756 | -46% | -$7.99M |
|
|
13
McKesson
MCK
$85.4B
| $8.93M | 2.35% | +29,168 | New | +$8.93M |
|
14
Cigna
CI
$80.3B
| $6.88M | 1.81% | 28,717 -7,929 | -22% | -$1.9M |
|
15
Elutia
ELUT
$96.7M
| $6.6M | 1.74% | 1,109,479 +33,839 | +3% | +$201K |
|
16
Edwards Lifesciences
EW
$47.8B
| $5.25M | 1.38% | +44,561 | New | +$5.25M |
|
17
Intuitive Surgical
ISRG
$170B
| $5.2M | 1.37% | +17,232 | New | +$5.2M |
|
18
Encompass Health
EHC
$12.3B
| $4.67M | 1.23% | +65,653 | New | +$4.67M |
|
19
Ocular Therapeutix
OCUL
$2.12B
| $4.57M | 1.2% | 923,963 +206,820 | +29% | +$1.02M |
|
|
ADAP
20
Adaptimmune Therapeutics
ADAP
$15.6M
| $4.45M | 1.17% | 2,160,890 +1,263,311 | +141% | +$2.6M |
|
21
Cartesian Therapeutics
RNAC
$261M
| $4.25M | 1.12% | 3,451,958 +1,328,432 | +63% | +$1.63M |
|
22
SPDR S&P Biotech ETF
XBI
$5.07B
| $4.17M | 1.1% | 46,440 -2,466 | -5% | -$222K |
|
23
Axsome Therapeutics
AXSM
$6.05B
| $4.15M | 1.09% | 100,299 +44,670 | +80% | +$1.85M |
|
24
AdaptHealth
AHCO
$1.28B
| $3.98M | 1.05% | 248,314 +150,388 | +154% | +$2.41M |
|
25
Insmed
INSM
$28.8B
| $3.88M | 1.02% | 165,280 +76,069 | +85% | +$1.79M |
|